Abstract:Melatonin is uncommonly effective in reducing oxidative stress under a remarkably large number of circumstances. It achieves this action via a variety of means: direct detoxification of reactive oxygen and reactive nitrogen species and indirectly by stimulating antioxidant enzymes while suppressing the activity of pro-oxidant enzymes. In addition to these well-described actions, melatonin also reportedly chelates transition metals, which are involved in the Fenton/Haber-Weiss reactions; in doing so, melatonin reduces the formation of the devastatingly toxic hydroxyl radical resulting in the reduction of oxidative stress. Melatonin's ubiquitous but unequal intracellular distribution, including its high concentrations in mitochondria, likely aid in its capacity to resist oxidative stress and cellular apoptosis. There is credible evidence to suggest that melatonin should be classified as a mitochondria-targeted antioxidant. Melatonin's capacity to prevent oxidative damage and the associated physiological debilitation is well documented in numerous experimental ischemia/reperfusion (hypoxia/reoxygenation) studies especially in the brain (stroke) and in the heart (heart attack). Melatonin, via its antiradical mechanisms, also reduces the toxicity of noxious prescription drugs and of methamphetamine, a drug of abuse. Experimental findings also indicate that melatonin renders treatment-resistant cancers sensitive to various therapeutic agents and may be useful, due to its multiple antioxidant actions, in especially delaying and perhaps treating a variety of age-related diseases and dehumanizing conditions. Melatonin has been effectively used to combat oxidative stress, inflammation and cellular apoptosis and to restore tissue function in a number of human trials; its efficacy supports its more extensive use in a wider variety of human studies. The uncommonly high-safety profile of melatonin also bolsters this conclusion. It is the current feeling of the authors that, in view of the widely diverse beneficial functions that have been reported for melatonin, these may be merely epiphenomena of the more fundamental, yet-to-be identified basic action(s) of this ancient molecule.

Evaluating the Oxidative Stress in Inflammation: Role of Melatonin

Melatonin as a Mediator of the Gut Microbiota-Host Interaction: Implications for Health and Disease

Melatonin as a natural ally against oxidative stress: a physicochemical examination

Role of Melatonin in the Inflammatory Process and its Therapeutic Potential

Melatonin as an antioxidant: under promises but over delivers

Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review

Melatonin and its relation to the immune system and inflammation

Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders

Actions of Melatonin in the Reduction of Oxidative Stress

Progress on the role of melatonin in resisting oxidative stress

Melatonin: a Well‐documented Antioxidant with Conditional Pro‐oxidant Actions

Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease

Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases

Is Melatonin the Cornucopia of the 21st Century?

Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells.

Melatonin and its role in oxidative stress related diseases of oral cavity

Oxidative Toxicity in Models of Neurodegeneration: Responses to Melatonin

Antiinflammatory Activity of Melatonin in Central Nervous System

Effect of melatonin on oxidative stress indicators in animal models of fibrosis: A systematic review and meta-analysis

Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress

Melatonin and oral diseases: possible therapeutic roles based on cellular mechanisms